Annual CFF
-$218.80 M
+$206.80 M+48.59%
December 31, 2024
Summary
- As of February 26, 2025, BIO annual cash flow from financing activities is -$218.80 million, with the most recent change of +$206.80 million (+48.59%) on December 31, 2024.
- During the last 3 years, BIO annual CFF has fallen by -$163.37 million (-294.74%).
- BIO annual CFF is now -122.47% below its all-time high of $973.60 million, reached on December 31, 2022.
Performance
BIO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$26.25 M
+$69.74 M+72.65%
December 31, 2024
Summary
- As of February 26, 2025, BIO quarterly cash flow from financing activities is -$26.25 million, with the most recent change of +$69.74 million (+72.65%) on December 31, 2024.
- Over the past year, BIO quarterly CFF has dropped by -$26.27 million (-125090.48%).
- BIO quarterly CFF is now -102.21% below its all-time high of $1.19 billion, reached on March 31, 2022.
Performance
BIO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
-$218.80 M
+$174.32 M+44.34%
December 31, 2024
Summary
- As of February 26, 2025, BIO TTM cash flow from financing activities is -$218.80 million, with the most recent change of +$174.32 million (+44.34%) on December 31, 2024.
- Over the past year, BIO TTM CFF has increased by +$211.09 million (+49.10%).
- BIO TTM CFF is now -118.51% below its all-time high of $1.18 billion, reached on March 31, 2022.
Performance
BIO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
BIO Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +48.6% | -10000.0% | +49.1% |
| 3 y3 years | -294.7% | +69.7% | -122.5% |
| 5 y5 years | -861.4% | +69.7% | -122.5% |
BIO Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -122.5% | +48.6% | -102.2% | +87.0% | -118.5% | +49.1% |
| 5 y | 5-year | -122.5% | +58.2% | -102.2% | +93.8% | -118.5% | +58.2% |
| alltime | all time | -122.5% | +58.2% | -102.2% | +93.8% | -118.5% | +58.2% |
Bio-Rad Laboratories Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$218.80 M(-48.6%) | -$26.25 M(-72.7%) | -$218.80 M(-44.3%) |
| Sep 2024 | - | -$95.99 M(-0.6%) | -$393.13 M(+21.4%) |
| Jun 2024 | - | -$96.59 M(<-9900.0%) | -$323.74 M(-24.7%) |
| Mar 2024 | - | $21.00 K(-100.0%) | -$429.89 M(+1.0%) |
| Dec 2023 | -$425.60 M(-143.7%) | -$200.57 M(+654.1%) | -$425.60 M(+36.6%) |
| Sep 2023 | - | -$26.60 M(-86.9%) | -$311.62 M(+6.1%) |
| Jun 2023 | - | -$202.74 M(-4805.0%) | -$293.80 M(+38.3%) |
| Mar 2023 | - | $4.31 M(-105.0%) | -$212.38 M(-121.8%) |
| Dec 2022 | $973.60 M(-1856.5%) | -$86.59 M(+887.2%) | $973.60 M(-8.6%) |
| Sep 2022 | - | -$8.77 M(-92.8%) | $1.06 B(+0.6%) |
| Jun 2022 | - | -$121.33 M(-110.2%) | $1.06 B(-10.5%) |
| Mar 2022 | - | $1.19 B(>+9900.0%) | $1.18 B(-2232.8%) |
| Dec 2021 | -$55.43 M(-89.4%) | $4.63 M(-129.7%) | -$55.43 M(-88.5%) |
| Sep 2021 | - | -$15.58 M(-643.9%) | -$481.95 M(+3.4%) |
| Jun 2021 | - | $2.87 M(-106.1%) | -$465.93 M(-1.2%) |
| Mar 2021 | - | -$47.35 M(-88.8%) | -$471.77 M(-9.8%) |
| Dec 2020 | -$523.04 M(+2198.3%) | -$421.88 M(<-9900.0%) | -$523.04 M(+393.7%) |
| Sep 2020 | - | $439.00 K(-114.7%) | -$105.94 M(-4.4%) |
| Jun 2020 | - | -$2.98 M(-97.0%) | -$110.87 M(-10.3%) |
| Mar 2020 | - | -$98.62 M(+1961.8%) | -$123.54 M(+442.8%) |
| Dec 2019 | -$22.76 M(-53.2%) | -$4.78 M(+6.5%) | -$22.76 M(-65.0%) |
| Sep 2019 | - | -$4.49 M(-71.3%) | -$64.98 M(+3.7%) |
| Jun 2019 | - | -$15.64 M(-824.0%) | -$62.66 M(+27.8%) |
| Mar 2019 | - | $2.16 M(-104.6%) | -$49.03 M(+0.7%) |
| Dec 2018 | -$48.68 M(<-9900.0%) | -$47.00 M(+2060.1%) | -$48.68 M(-2663.5%) |
| Sep 2018 | - | -$2.18 M(+7.9%) | $1.90 M(+53.8%) |
| Jun 2018 | - | -$2.02 M(-180.2%) | $1.24 M(-43.4%) |
| Mar 2018 | - | $2.52 M(-29.7%) | $2.18 M(+540.2%) |
| Dec 2017 | $341.00 K(-96.2%) | $3.58 M(-225.9%) | $341.00 K(-184.0%) |
| Sep 2017 | - | -$2.84 M(+165.9%) | -$406.00 K(-107.6%) |
| Jun 2017 | - | -$1.07 M(-258.7%) | $5.33 M(-43.5%) |
| Mar 2017 | - | $673.00 K(-76.2%) | $9.44 M(+4.6%) |
| Dec 2016 | $9.02 M(+5.1%) | $2.83 M(-2.3%) | $9.02 M(-9.1%) |
| Sep 2016 | - | $2.90 M(-4.6%) | $9.92 M(+8.5%) |
| Jun 2016 | - | $3.04 M(+1076.7%) | $9.14 M(-0.3%) |
| Mar 2016 | - | $258.00 K(-93.1%) | $9.17 M(+6.9%) |
| Dec 2015 | $8.58 M(-26.6%) | $3.73 M(+75.6%) | $8.58 M(+1.2%) |
| Sep 2015 | - | $2.12 M(-30.6%) | $8.48 M(+4.4%) |
| Jun 2015 | - | $3.06 M(-1024.8%) | $8.12 M(+3.2%) |
| Mar 2015 | - | -$331.00 K(-109.1%) | $7.87 M(-32.7%) |
| Dec 2014 | $11.69 M(-103.8%) | $3.63 M(+105.3%) | $11.69 M(-1.2%) |
| Sep 2014 | - | $1.77 M(-37.1%) | $11.83 M(-104.0%) |
| Jun 2014 | - | $2.81 M(-19.5%) | -$299.26 M(-0.5%) |
| Mar 2014 | - | $3.49 M(-7.4%) | -$300.78 M(-3.5%) |
| Dec 2013 | -$311.70 M(-2576.1%) | $3.77 M(-101.2%) | -$311.70 M(-0.1%) |
| Sep 2013 | - | -$309.33 M(<-9900.0%) | -$311.95 M(>+9900.0%) |
| Jun 2013 | - | $1.29 M(-117.4%) | -$67.00 K(-104.6%) |
| Mar 2013 | - | -$7.43 M(-311.3%) | $1.44 M(-88.5%) |
| Dec 2012 | $12.59 M(-105.9%) | $3.52 M(+37.6%) | $12.59 M(+71.5%) |
| Sep 2012 | - | $2.55 M(-8.8%) | $7.34 M(+7.3%) |
| Jun 2012 | - | $2.80 M(-24.7%) | $6.84 M(+39.6%) |
| Mar 2012 | - | $3.72 M(-314.6%) | $4.90 M(-102.3%) |
| Dec 2011 | -$213.56 M(-193.4%) | -$1.73 M(-184.3%) | -$213.56 M(-2302.8%) |
| Sep 2011 | - | $2.06 M(+139.1%) | $9.70 M(-9.1%) |
| Jun 2011 | - | $860.00 K(-100.4%) | $10.67 M(-17.7%) |
| Mar 2011 | - | -$214.74 M(-196.9%) | $12.97 M(-94.3%) |
| Dec 2010 | $228.75 M(-22.2%) | $221.52 M(+7206.1%) | $228.75 M(+2472.2%) |
| Sep 2010 | - | $3.03 M(-4.0%) | $8.89 M(+26.7%) |
| Jun 2010 | - | $3.16 M(+205.7%) | $7.02 M(-97.6%) |
| Mar 2010 | - | $1.03 M(-38.1%) | $297.01 M(+1.0%) |
| Dec 2009 | $293.93 M(+4542.8%) | $1.67 M(+44.2%) | $293.93 M(-0.1%) |
| Sep 2009 | - | $1.16 M(-99.6%) | $294.19 M(+0.1%) |
| Jun 2009 | - | $293.15 M(<-9900.0%) | $293.76 M(>+9900.0%) |
| Mar 2009 | - | -$2.04 M(-206.3%) | $1.50 M(-76.3%) |
| Dec 2008 | $6.33 M(-185.0%) | $1.92 M(+162.2%) | $6.33 M(-140.5%) |
| Sep 2008 | - | $733.00 K(-17.4%) | -$15.63 M(+19.1%) |
| Jun 2008 | - | $887.00 K(-68.2%) | -$13.13 M(+10.1%) |
| Mar 2008 | - | $2.79 M(-113.9%) | -$11.93 M(+60.1%) |
| Dec 2007 | -$7.45 M | -$20.04 M(-719.5%) | -$7.45 M(-156.5%) |
| Sep 2007 | - | $3.23 M(+54.8%) | $13.19 M(+1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2007 | - | $2.09 M(-71.2%) | $12.98 M(-11.9%) |
| Mar 2007 | - | $7.26 M(+1110.8%) | $14.73 M(+45.0%) |
| Dec 2006 | $10.16 M(+687.8%) | $600.00 K(-80.2%) | $10.16 M(+60.1%) |
| Sep 2006 | - | $3.03 M(-21.2%) | $6.35 M(+132.3%) |
| Jun 2006 | - | $3.84 M(+42.4%) | $2.73 M(+129.5%) |
| Mar 2006 | - | $2.70 M(-183.9%) | $1.19 M(-7.7%) |
| Dec 2005 | $1.29 M(-99.3%) | -$3.21 M(+445.5%) | $1.29 M(-99.4%) |
| Sep 2005 | - | -$589.00 K(-125.6%) | $204.24 M(+4.7%) |
| Jun 2005 | - | $2.30 M(-17.8%) | $195.07 M(-0.5%) |
| Mar 2005 | - | $2.79 M(-98.6%) | $196.05 M(+1.5%) |
| Dec 2004 | $193.23 M(+78.6%) | $199.73 M(-2146.9%) | $193.23 M(-3677.6%) |
| Sep 2004 | - | -$9.76 M(-397.8%) | -$5.40 M(-104.8%) |
| Jun 2004 | - | $3.28 M(<-9900.0%) | $112.69 M(+1.9%) |
| Mar 2004 | - | -$24.00 K(-102.2%) | $110.56 M(+2.2%) |
| Dec 2003 | $108.17 M(-236.7%) | $1.10 M(-99.0%) | $108.17 M(+53.4%) |
| Sep 2003 | - | $108.34 M(+9403.2%) | $70.52 M(-250.3%) |
| Jun 2003 | - | $1.14 M(-147.3%) | -$46.90 M(-32.5%) |
| Mar 2003 | - | -$2.41 M(-93.4%) | -$69.54 M(-12.1%) |
| Dec 2002 | -$79.13 M(+292.5%) | -$36.55 M(+302.3%) | -$79.13 M(+42.6%) |
| Sep 2002 | - | -$9.08 M(-57.7%) | -$55.49 M(+18.4%) |
| Jun 2002 | - | -$21.49 M(+79.1%) | -$46.86 M(+43.8%) |
| Mar 2002 | - | -$12.00 M(-7.0%) | -$32.58 M(+61.6%) |
| Dec 2001 | -$20.16 M(-51.5%) | -$12.91 M(+2750.1%) | -$20.16 M(+82.4%) |
| Sep 2001 | - | -$453.00 K(-93.7%) | -$11.06 M(-76.7%) |
| Jun 2001 | - | -$7.21 M(-1838.1%) | -$47.47 M(-3.9%) |
| Mar 2001 | - | $415.00 K(-110.9%) | -$49.38 M(+18.7%) |
| Dec 2000 | -$41.61 M(-122.8%) | -$3.81 M(-89.7%) | -$41.61 M(-126.9%) |
| Sep 2000 | - | -$36.87 M(+304.3%) | $154.40 M(-16.8%) |
| Jun 2000 | - | -$9.12 M(-211.4%) | $185.67 M(-3.4%) |
| Mar 2000 | - | $8.19 M(-95.7%) | $192.19 M(+5.4%) |
| Dec 1999 | $182.30 M(<-9900.0%) | $192.20 M(-3532.1%) | $182.30 M(-1727.7%) |
| Sep 1999 | - | -$5.60 M(+115.4%) | -$11.20 M(-24.8%) |
| Jun 1999 | - | -$2.60 M(+52.9%) | -$14.90 M(+50.5%) |
| Mar 1999 | - | -$1.70 M(+30.8%) | -$9.90 M(+1000.0%) |
| Dec 1998 | -$900.00 K(-102.7%) | -$1.30 M(-86.0%) | -$900.00 K(-102.3%) |
| Sep 1998 | - | -$9.30 M(-487.5%) | $39.20 M(-16.2%) |
| Jun 1998 | - | $2.40 M(-67.1%) | $46.80 M(+28.2%) |
| Mar 1998 | - | $7.30 M(-81.2%) | $36.50 M(+9.0%) |
| Dec 1997 | $33.50 M(-232.9%) | $38.80 M(-2382.4%) | $33.50 M(-238.4%) |
| Sep 1997 | - | -$1.70 M(-78.5%) | -$24.20 M(+13.1%) |
| Jun 1997 | - | -$7.90 M(-283.7%) | -$21.40 M(+25.9%) |
| Mar 1997 | - | $4.30 M(-122.8%) | -$17.00 M(-32.5%) |
| Dec 1996 | -$25.20 M(+92.4%) | -$18.90 M(-1818.2%) | -$25.20 M(+133.3%) |
| Sep 1996 | - | $1.10 M(-131.4%) | -$10.80 M(-27.0%) |
| Jun 1996 | - | -$3.50 M(-10.3%) | -$14.80 M(-7.5%) |
| Mar 1996 | - | -$3.90 M(-13.3%) | -$16.00 M(+22.1%) |
| Dec 1995 | -$13.10 M(-60.2%) | -$4.50 M(+55.2%) | -$13.10 M(-20.6%) |
| Sep 1995 | - | -$2.90 M(-38.3%) | -$16.50 M(-10.3%) |
| Jun 1995 | - | -$4.70 M(+370.0%) | -$18.40 M(-25.5%) |
| Mar 1995 | - | -$1.00 M(-87.3%) | -$24.70 M(-24.9%) |
| Dec 1994 | -$32.90 M(+116.4%) | -$7.90 M(+64.6%) | -$32.90 M(-25.2%) |
| Sep 1994 | - | -$4.80 M(-56.4%) | -$44.00 M(-0.9%) |
| Jun 1994 | - | -$11.00 M(+19.6%) | -$44.40 M(+69.5%) |
| Mar 1994 | - | -$9.20 M(-51.6%) | -$26.20 M(+72.4%) |
| Dec 1993 | -$15.20 M(-994.1%) | -$19.00 M(+265.4%) | -$15.20 M(-235.7%) |
| Sep 1993 | - | -$5.20 M(-172.2%) | $11.20 M(-1966.7%) |
| Jun 1993 | - | $7.20 M(+300.0%) | -$600.00 K(-154.5%) |
| Mar 1993 | - | $1.80 M(-75.7%) | $1.10 M(-35.3%) |
| Dec 1992 | $1.70 M(-93.3%) | $7.40 M(-143.5%) | $1.70 M(-177.3%) |
| Sep 1992 | - | -$17.00 M(-291.0%) | -$2.20 M(-108.2%) |
| Jun 1992 | - | $8.90 M(+270.8%) | $26.80 M(+30.7%) |
| Mar 1992 | - | $2.40 M(-31.4%) | $20.50 M(-19.3%) |
| Dec 1991 | $25.40 M(+243.2%) | $3.50 M(-70.8%) | $25.40 M(-0.4%) |
| Sep 1991 | - | $12.00 M(+361.5%) | $25.50 M(+96.2%) |
| Jun 1991 | - | $2.60 M(-64.4%) | $13.00 M(-5.8%) |
| Mar 1991 | - | $7.30 M(+102.8%) | $13.80 M(+86.5%) |
| Dec 1990 | $7.40 M(+23.3%) | $3.60 M(-820.0%) | $7.40 M(+94.7%) |
| Sep 1990 | - | -$500.00 K(-114.7%) | $3.80 M(-11.6%) |
| Jun 1990 | - | $3.40 M(+277.8%) | $4.30 M(+377.8%) |
| Mar 1990 | - | $900.00 K | $900.00 K |
| Dec 1989 | $6.00 M | - | - |
FAQ
- What is Bio-Rad Laboratories annual cash flow from financing activities?
- What is the all time high annual CFF for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories annual CFF year-on-year change?
- What is Bio-Rad Laboratories quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories quarterly CFF year-on-year change?
- What is Bio-Rad Laboratories TTM cash flow from financing activities?
- What is the all time high TTM CFF for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories TTM CFF year-on-year change?
What is Bio-Rad Laboratories annual cash flow from financing activities?
The current annual CFF of BIO is -$218.80 M
What is the all time high annual CFF for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high annual cash flow from financing activities is $973.60 M
What is Bio-Rad Laboratories annual CFF year-on-year change?
Over the past year, BIO annual cash flow from financing activities has changed by +$206.80 M (+48.59%)
What is Bio-Rad Laboratories quarterly cash flow from financing activities?
The current quarterly CFF of BIO is -$26.25 M
What is the all time high quarterly CFF for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high quarterly cash flow from financing activities is $1.19 B
What is Bio-Rad Laboratories quarterly CFF year-on-year change?
Over the past year, BIO quarterly cash flow from financing activities has changed by -$26.27 M (-125090.48%)
What is Bio-Rad Laboratories TTM cash flow from financing activities?
The current TTM CFF of BIO is -$218.80 M
What is the all time high TTM CFF for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high TTM cash flow from financing activities is $1.18 B
What is Bio-Rad Laboratories TTM CFF year-on-year change?
Over the past year, BIO TTM cash flow from financing activities has changed by +$211.09 M (+49.10%)